William J. Gradishar, MD, highlights the inclusion of abemaciclib in the NCCN Guidelines for select high-risk early-stage breast cancer patients, anticipates the potential for ribociclib to secure a similar guideline position, and emphasizes the importance of monitoring treatment response. ...
Guidelines for early breast cancer treatment updateddoi:10.1007/BF03276514Springer International PublishingPharmacoEconomics & Outcomes News
Breast Cancer in the Elderly: Retrospective Study on Diagnosis and Treatment According to National Guidelines Abstract: We set out to investigate the level of accordance of diagnosis and treatment of elderly breast cancer patients with national guidelines and t... ME Hamaker,WH Schreurs,JM Uppel...
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up - ScienceDirect of the esmo Guidelines Working Group Locally recurrent or metastatic breast cancer: esmo clinical practice guidelines for diagnosis, treatment and follow-up. ... F Car...
SEOM Clinical Guidelines for the systemic treatment of early breast cancer 2013 The purpose of this article is to update our previous work on the treatment and follow-up in early breast cancer. In this new version we have classified a ... SD Barco,E Ciruelos,I Tusquets,... - 《...
Surgery is considered primary treatment for early-stage breast cancer; many patients are cured with surgery alone. The goals of breast cancer surgery include complete resection of the primary tumor with negative margins to reduce the risk of local recurrences and pathologic staging of the tumor and...
What things will affect your treatment plan for early breast cancer? Test yourself on what you know.
Primary treatment of early breast cancer with conservation surgery and radiation therapy. The effect of adjuvant chemotherapy The combination of radiation therapy (RT) and conservation surgery is appropriate treatment for Stage I and II breast cancer patients, and is equivalent to... Seymour,H.,...
From 1995 on, many relevant advances in early breast cancer (BC) treatment have contributed to the improvement in patient survival. For instance, the emergence of anthracycline1 and taxane-based therapies2 and the identification of intrinsic subtypes3. Several guidelines for treating breast cancer pat...
A clinical decision analysis was performed to judge the impact of local recurrences after breast-conserving treatment (BCT) on the (quality-adjusted) life expectancy of breast cancer patients. A life-long follow-up of two patient groups, one of which had undergone mastectomy and one BCT, was ...